Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
DANIPHARM A/S
A/S
Active
CVR 12335040
Englandsvej 350-356, 2770
Kastrup
Manufacture of basic pharmaceutical products
·
NACE 2110
Est. 1988 · 37 years old
24 employees
Overvåg
Share
Denmark
/
Companies
/
Manufacture of basic pharmaceutical products
/
DANIPHARM A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
11M
22M
33M
44M
29M
2021
35M
2022
35M
2023
34M
2024
38M
2025
EBITDA
DKK millions
24M
18M
12M
6M
0M
7M
2021
12M
+71%
2022
10M
-17%
2023
9M
-10%
2024
19M
+111%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
29.395
34.935
35.152
34.065
37.587
Staff expenses
-22.491
-23.416
-24.795
-24.886
-18.442
EBITDA
6.903
11.519
10.356
9.179
19.145
Depreciation & amort.
-2.334
-2.302
-2.300
-2.152
-2.083
EBIT
4.569
9.217
8.056
7.028
17.062
Net financials
-797
1.282
-1.151
-476
521
Profit before tax
3.772
10.499
6.906
6.552
17.583
Tax
828
2.308
1.515
1.438
3.866
Net profit
2.944
8.191
5.391
5.114
13.717
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
73.178
78.307
87.076
95.569
112.993
Equity
29.869
36.059
41.450
46.564
60.281
Long-term debt
3.200
0
0
1.659
3.956
Short-term debt
38.301
40.447
43.781
45.722
47.221
Total debt
41.501
40.447
43.781
47.381
51.177
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
50.9%
This company
2021
2025
Soliditetsgrad
53.3%
This company
38.2%
Market median
+40% vs market
2021
2025
Egenkapitalforrentning
22.8%
This company
18.4%
Market median
+24% vs market
2021
2025
Nettoresultatgrad (af bruttofortjeneste)
36.5%
This company
2021
2025
Aktivomsætning (af bruttofortjeneste)
0.33×
This company
2021
2025
Gæld/egenkapital
0.87×
This company
0.62×
Market median
+40% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
View
PDF
More on DANIPHARM A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
